Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Muscat

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Disruption of hippocampal mitochondrial function underlies opioid-induced postoperative cognitive dysfunction in aged ratsStephanie M Muscat, Nicholas P Deems, Bryan D Alvarez, et al.
Cancer Cell|April 29, 2022
Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibitionJustin T Low, Vidyalakshmi Chandramohan, Michelle L Bowie, et al.
Nature Communications|January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapyMatthias Gromeier, Michael C Brown, Gao Zhang, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Disruption of hippocampal mitochondrial function underlies opioid-induced postoperative cognitive dysfunction in aged ratsStephanie M Muscat, Nicholas P Deems, Bryan D Alvarez, et al.
Cancer Cell|April 29, 2022
Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibitionJustin T Low, Vidyalakshmi Chandramohan, Michelle L Bowie, et al.
Nature Communications|January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapyMatthias Gromeier, Michael C Brown, Gao Zhang, et al.
Pageof 12